
£257.39
Mounjaro contains tirzepatide and is a prescription-only, once-weekly injection used for weight management in eligible adults. It is prescribed alongside a reduced-calorie diet and increased physical activity. Mounjaro acts on the GIP and GLP-1 hormone pathways, which are involved in appetite and blood glucose regulation.
The current UK product information confirms that the 10 mg KwikPen is a multi-dose pre-filled pen containing four 0.6 ml doses, with 10 mg delivered per weekly dose.
Mounjaro is the brand name for tirzepatide, a medicine licensed in the UK to treat obesity and support weight loss in eligible adults. Tirzepatide was first developed to help manage type 2 diabetes by improving blood sugar control — and because patients also saw meaningful weight loss, it was approved for weight management in 2023.¹
Today, Mounjaro is taken as a single weekly injection from an easy-to-use pen, making it a convenient option for people who have not reached their goals through diet and exercise alone.
Mounjaro is prescribed as part of a wider plan that includes a reduced-calorie diet and increased physical activity. You may be eligible if you have:
• A BMI of 30 kg/m² or above, or
• A BMI of 27–30 kg/m² together with at least one weight-related health condition.
It is designed to support weight loss alongside lifestyle changes and improve health outcomes for people at higher risk because of their weight. Our clinicians will confirm whether Mounjaro is appropriate for you during your consultation.

Mounjaro is not suitable for everyone. Your clinician will review your medical history, current medicines, allergies, pregnancy or breastfeeding status, and any history of pancreatic or significant digestive conditions before deciding whether treatment is appropriate.
Always provide complete and accurate information during your consultation so our clinicians can prescribe safely.

Mounjaro comes in a pre-filled KwikPen and is injected just under the skin once a week. When the administration instructions are followed, it can be used at home.

You can inject into:
• Stomach — at least 5 cm (2 inches) away from your belly button
• Thigh — the front of either thigh, avoiding the inner thigh
• Upper arm — the back of the arm, if someone else is injecting for you
Rotate the injection site each week and avoid skin that is bruised, red, sore or irritated. Use a new needle for every injection and dispose of the used needle safely in a sharps bin.

Mounjaro works differently from most weight-loss medicines because it acts on two hormone pathways at once:
• Curbs appetite — it works on the hormones that tell your brain you are full, so you feel satisfied with less food.
• Improves insulin response — it helps your body use insulin more effectively, keeping blood sugar steadier and reducing energy dips.
• Supports fat metabolism — it raises adiponectin, a hormone involved in regulating glucose and breaking down fat.
• Lasts the week — with a half-life of around five days, one injection keeps working for a full week.
• Clinical trial results — in studies, participants saw average weight reductions of roughly 16–22% over 72 weeks, including people without diabetes.²
Mounjaro works best as part of a supported plan. With Lyv, your prescription comes with clinician review, dose adjustments, and guidance to help you build lasting habits around food, movement and sleep.


1
Take our assessment
Share your goals, health history, and current medicines so we can check eligibility safely.

2
Select an option with your clinician
A UK clinician will review your assessment and recommend a suitable treatment option based on your health needs and goals.

3
Receive your treatment
Your treatment arrives in free, discreet packaging, with clear storage and step-by-step instructions.

4
Get on going support
We will help you build healthier habits and check in on your progress, side effects and any dose changes along the way.